title: Limited lists and the purchase of pharmaceutical products by government agencies in the RSA.
abstract: The use of a limited list to restrict the range and type of medication used by medical institutions that operate under the auspices of the provincial authorities has been mooted as one possible method of cost containment. This study discusses the implementation of such measures in other countries and then quantifies the cost savings that might be obtained in the South African case. The possible savings are somewhat offset by other costs such a measure would introduce.
authors.affiliation: Department of Business Economics, University of the Witwatersrand, Johannesburg.
authors.forename: M B
authors.initials: MB
authors.lastname: Cohen
authors.forename: D
authors.initials: D
authors.lastname: Stegelmeyer
mesh_terms: D003365:Costs and Cost Analysis; D003906:Developing Countries; D004345:Drug Industry; D004363:Drug Utilization / Q000191:economics; D005572:Formularies, Hospital as Topic; D013019:South Africa; D006113:United Kingdom; D015024:Zambia